Dr. Litton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-7090
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2007
Baylor College of MedicineResidency, Internal Medicine, 2000 - 2004
University of Massachusetts Medical SchoolClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2003 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Primary Breast Cancer Occurring Concomitant With Pregnancy Start of enrollment: 2001 Aug 07
- Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC) Start of enrollment: 2009 Feb 01
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- Sleep disturbances based on patient reported outcomes in patients with breast cancer.Saadia A Faiz, Ashley S Knox, Bryan Fellman, Bibi Aneesah Jaumally, G Nancy Pacheco
Sleep & Breathing = Schlaf & Atmung. 2024-12-01 - Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy.Helen M Johnson, Juhee Song, Carla L Warneke, Ashley L Martinez, Jennifer K Litton
Cancer. 2024-10-29 - Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.Clinton Yam, Miral Patel, Holly A Hill, Ryan Sun, Roland L Bassett Jr
Cancer Research Communications. 2024-10-01
Lectures
- Germline Testing in the PARP Inhibitor EraASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+).2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- Breast cancer during pregnancy and lactation: Epidemiology and diagnosisLitton JK, Theriault R
http://www.uptodate.com/contents/breast-cancer-during-pregnancy-and-lactation-epidemiology-and-diagn
UpToDate, Wolters Kluwer Health - 2012-05-15 - Breast cancer during pregnancy and lactation: TreatmentLitton JK, Theriault R
http://www.uptodate.com/contents/breast-cancer-during-pregnancy-and-lactation-treatment
UpToDate, Wolters Kluwer Health - 2013-01-07
Press Mentions
Jennifer Litton, MD, on Defining Endpoints for Neoadjuvant Breast Cancer TrialsSeptember 3rd, 2024- Anti-CDK4/6 in Metastatic Breast Cancer Showed Further Benefits at SABCSJanuary 24th, 2023
- After Breast Cancer, Women May Safely Stop Long-Term Therapies to Have a BabyDecember 8th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
